TRANSOESOPHAGEAL ECHOCARDIOGRAM BEFORE CARDIOVERSION IN PROPERLY ANTICOAGULATED PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION

A. Zebrauskaite, A. Aidietis, J. Barysiene, G. Marinskis, D. Petrikonyte

Clinic of Cardiovascular diseases, Vilnius University, Vilnius, Lithuania

Abstract

Introduction: To evaluate indications for transoesophageal echocardiogram (TEE) in properly anticoagulated patients before direct current cardioversion (DCC).
Methods: Retrospective analysis of 251 patients with non-valvular AF, appropriate anticoagulation before scheduled DCC (3 weeks of oral anticoagulation prior to DCC with AF>48h) who underwent DCC, TEE in 2012-2014 was analysed. CHA2DS2VASc, HAS-BLED, TE complications in 30 days after DCC were assessed.
Results: Mean patients age 65.3yrs. ±10,6. There were 97 females (38.6%, mean age 70.4 yrs. ±7,5) 154 males (61.4%, mean age 62.3 yrs. ±11,1). Appropriate anticoagulation achieved using warfarin in 200 (79.7%) and dabigatran in 51 (20.3%) patients. TEE was performed for 76 (30.3%) patients. For 4 patients (5,3%) thrombi in the left atrium (LA) were detected (3 patients on warfarin, 1 on dabigatran). CHA2DS2VASc score in patients with LA thrombi was ?4. SR was restored for 247 patients (98,4%). There were no TE complications after DCC.
Conclusions: The risk of LA thrombi is present in properly anticoagulated patients. Further studies are required to assess more accurate indications for TEE